A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy

NCT00361569 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

622

Enrollment

INDUSTRY

Sponsor class

Conditions

Menopause

Interventions

DRUG: DR-2041a
DRUG: DR-2041b
OTHER: Placebo
OTHER: Placebo

Sponsor

Duramed Research